Autochthonous hepatitis e in developed countries and HEV/HIV coinfection

Seminars in Liver Disease

Volumn 33, Issue 1, 2013, Pages 50-61

  Dalton, H R ^a,b   Hunter, J G ^a   Bendall, R ^a,b  

^a ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

chronic liver disease; epidemiology; hepatitis E virus; HEV; HIV; human immunodeficiency virus; pork

Indexed keywords

HEPATITIS E VACCINE; RIBAVIRIN;

ARTICLE; BELL PALSY; BLOOD TRANSFUSION; BRACHIAL PLEXUS NEUROPATHY; DEVELOPED COUNTRY; GUILLAIN BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; LIVER TRANSPLANTATION; MENINGOENCEPHALITIS; MIXED INFECTION; MYOPATHY; PRIORITY JOURNAL; SEROPREVALENCE;

COINFECTION; DEVELOPED COUNTRIES; HEPATITIS E; HIV INFECTIONS; HUMANS;

EID: 84875971187     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0033-1338114     Document Type: Article

References (113)

1. Khuroo M. S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med: 1980; 68 6 818 824
2. Wong D. C., Purcell R. H., Sreenivasan M. A., Prasad S. R., Pavri K. M. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet: 1980; 2 8200 876 879
3. Balayan M. S., Andjaparidze A. G., Savinskaya S. S., et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology: 1983; 20 1 23 31
4. Dalton H. R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis: 2008; 8 11 698 709
5. Teo C-G. Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiol Infect: 2012; 140 5 767 787
6. Kerksig F. Of a jaundice epidemic [in German]. Journal der Practischen Arzneykunde und Wundarzneykunst: 1799; 8 94 109
7. Saint-Vel O. Note on a form of severe jaundice in pregnant women [in French]. Gazette des Hôpitaux Civils et Militaires: 1862; 65 538 539
8. Ballot. Jaundice epidemic observed in 1858 in Martinique in the Principality of St. Pierre [in French]. Gazette des Hôpitaux Civils et Militaires: 1859; 62 262
9. Purdy M. A., Khudyakov Y. E. Evolutionary history and population dynamics of hepatitis E virus. PLoS ONE: 2010; 5 12 e14376
10. Zaaijer H. L., Kok M., Lelie P. N., Timmerman R. J., Chau K., van der Pal H. J. Hepatitis E in The Netherlands: imported and endemic. Lancet: 1993; 341 8848 826
11. Zanetti A. R., Dawson G. J. Study Group of Hepatitis E Hepatitis type E in Italy: a seroepidemiological survey. J Med Virol: 1994; 42 3 318 320
12. Dalton H. R., Stableforth W., Thurairajah P., et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol: 2008; 20 8 784 790
13. Christensen P. B., Engle R. E., Hjort C., et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis: 2008; 47 8 1026 1031
14. Kuniholm M. H., Purcell R. H., McQuillan G. M., Engle R. E., Wasley A., Nelson K. E. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis: 2009; 200 1 48 56
15. Beale M. A., Tettmar K., Szypulska R., Tedder R. S., Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang: 2011; 100 3 340 342
16. Boutrouille A., Bakkali-Kassimi L., Crucière C., Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol: 2007; 45 6 2009 2010
17. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol: 2010; 82 5 799 805
18. Mansuy J. M., Bendall R., Legrand-Abravanel F., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis: 2011; 17 12 2309 2312
19. Dalton H. R., Fellows H. J., Gane E. J., et al. Hepatitis E in New Zealand. J Gastroenterol Hepatol: 2007; 22 8 1236 1240
20. Legrand-Abravanel F., Kamar N., Sandres-Saune K., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis: 2011; 17 1 30 37
21. Drobeniuc J., Favorov M. O., Shapiro C. N., et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis: 2001; 184 12 1594 1597
22. Meng X. J., Wiseman B., Elvinger F., et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol: 2002; 40 1 117 122
23. Berto A., Martelli F., Grierson S., Banks M. Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerg Infect Dis: 2012; 18 8 1358 1360
24. Colson P., Borentain P., Queyriaux B., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis: 2010; 202 6 825 834
25. Feagins A. R., Opriessnig T., Guenette D. K., Halbur P. G., Meng X. J. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol: 2007; 88 Pt 3 912 917
26. Yazaki Y., Mizuo H., Takahashi M., et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol: 2003; 84 Pt 9 2351 2357
27. Banks M., Martelli F., Grierson S., et al. Hepatitis E virus in retail pig livers. Vet Rec: 2010; 166 1 29
28. Matsuda H., Okada K., Takahashi K., Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis: 2003; 188 6 944
29. Wichmann O., Schimanski S., Koch J., et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis: 2008; 198 12 1732 1741
30. Rutjes S. A., Lodder W. J., Lodder-Verschoor F., et al. Sources of hepatitis E virus genotype 3 in The Netherlands. Emerg Infect Dis: 2009; 15 3 381 387
31. Ijaz S., Arnold E., Banks M., et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis: 2005; 192 7 1166 1172
32. Madden R. G., Hunter J. G., Stone A. M., et al. Locally acquired hepatitis E. Geographical clustering and environmental factors: a nested case control study. J Hepatol: 2012; 56 02 s64
33. Brassard J., Gagné M. J., Généreux M., Côté C. Detection of human food-borne and zoonotic viruses on irrigated, field-grown strawberries. Appl Environ Microbiol: 2012; 78 10 3763 3766
34. Crossan C., Baker P. J., Craft J., Takeuchi Y., Dalton H. R., Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis: 2012; 18 12 2085 2087
35. Li T. C., Miyamura T., Takeda N. Detection of hepatitis E virus RNA from the bivalve Yamato-Shijimi (Corbicula japonica) in Japan. Am J Trop Med Hyg: 2007; 76 1 170 172
36. Donia D., Dell'Amico M. C., Petrinca A. R., et al. Presence of hepatitis E RNA in mussels used as bio-monitors of viral marine pollution. J Virol Methods: 2012; 186 1-2 198 202
37. Said B., Ijaz S., Kafatos G., et al. Hepatitis E Incident Investigation Team Hepatitis E outbreak on cruise ship. Emerg Infect Dis: 2009; 15 11 1738 1744
38. Tsang T. H., Denison E. K., Williams H. V., Venczel L. V., Ginsberg M. M., Vugia D. J. Acute hepatitis E infection acquired in California. Clin Infect Dis: 2000; 30 3 618 619
39. Mansuy J. M., Peron J. M., Abravanel F., et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol: 2004; 74 3 419 424
40. Dalton H. R., Thurairajah P. H., Fellows H. J., et al. Autochthonous hepatitis E in southwest England. J Viral Hepat: 2007; 14 5 304 309
41. Mizuo H., Yazaki Y., Sugawara K., et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol: 2005; 76 3 341 349
42. Colson P., Romanet P., Moal V., et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis: 2012; 18 8 1361 1364
43. Krawczynski K. Hepatitis E. Hepatology: 1993; 17 5 932 941
44. Aggarwal R., Kamili S., Spelbring J., Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J Infect Dis: 2001; 184 11 1380 1385
45. Dalton H. R., Bendall R. P., Rashid M., et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol: 2011; 23 12 1200 1205
46. Vine L. J., Shepherd K., Hunter J. G., et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther: 2012; 36 1 16 21
47. Kamar N., Bendall R. P., Peron J. M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis: 2011; 17 2 173 179
48. Dalton H. R., Fellows H. J., Stableforth W., et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther: 2007; 26 10 1429 1435
49. Davern T. J., Chalasani N., Fontana R. J., et al. Drug-Induced Liver Injury Network (DILIN) Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology: 2011; 141 5 1665 1672, e1-e9
50. Andersson M. I., Hughes J., Gordon F. H., Ijaz S., Donati M. Of pigs and pregnancy. Lancet: 2008; 372 9644 1192
51. Dalton H. R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet: 2007; 369 9569 1260
52. Péron J. M., Bureau C., Poirson H., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat: 2007; 14 5 298 303
53. Nanji A. A., French S. W. Relationship between pork consumption and cirrhosis. Lancet: 1985; 1 8430 681 683
54. Dalton H. R., Bendall R. P., Pritchard C., Henley W., Melzer D. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect: 2010; 138 2 174 182
55. Di Bartolo I., Diez-Valcarce M., Vasickova P., et al. Hepatitis E virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerg Infect Dis: 2012; 18 8 1282 1289
56. Barnaud E., Rogée S., Garry P., Rose N., Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol: 2012; 78 15 5153 5159
57. Péron J. M., Mansuy J. M., Poirson H., et al. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol: 2006; 30 5 757 762
58. Mitsui T., Tsukamoto Y., Hirose A., et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol: 2006; 78 8 1015 1024
59. Health Protection Agency Available at: http://www.hpa.org.uk/hpr/ archives/2012/news3212.htm. Accessed September 13, 2012
60. Scobie L., Dalton H. R. Hepatitis E: Source and route of infection, clinical manifestations and new developments. J Viral Hepat: 2013; 20 1 1 11
61. Faramawi M. F., Johnson E., Chen S., Pannala P. R. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect: 2011; 139 8 1145 1150
62. Peron J. M., Danjoux M., Kamar N., et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France. Virchows Arch: 2007; 450 4 405 410
63. Malcolm P., Dalton H., Hussaini H. S., Mathew J. The histology of acute autochthonous hepatitis E virus infection. Histopathology: 2007; 51 2 190 194
64. Lockwood G. L., Fernandez-Barredo S., Bendall R., Banks M., Ijaz S., Dalton H. R. Hepatitis E autochthonous infection in chronic liver disease. Eur J Gastroenterol Hepatol: 2008; 20 8 800 803
65. Sood A., Midha V., Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol: 2000; 95 12 3667 3668
66. Dixit V. K., Abhilash V. B., Kate M. P., Jain A. K. Hepatitis E infection with Bell's palsy. J Assoc Physicians India: 2006; 54 418
67. Fong F., Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg: 2009; 111 2 193 195
68. Mandal K., Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr: 2006; 43 4 365 366
69. Kejariwal D., Roy S., Sarkar N. Seizure associated with acute hepatitis E. Neurology: 2001; 57 10 1935
70. Del Bello A., Arné-Bes M. C., Lavayssière L., Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol: 2012; 57 5 1152 1153 [Epub ahead of print]
71. Maurissen I., Jeurissen A., Strauven T., Sprengers D., De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection. Infection: 2012; 40 3 323 326
72. Despierres L. A., Kaphan E., Attarian S., et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis: 2011; 17 8 1510 1512
73. Dalton H. R., Keane F. E., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med: 2011; 155 7 479 480
74. Kamar N., Izopet J., Cintas P., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant: 2010; 10 5 1321 1324
75. Kamar N., Weclawiack H., Guilbeaud-Frugier C., et al. Impact of hepatitis E virus infection on kidney function and histology in organ-transplant patients. Am J Transplant: 2011;; Abstract 864
76. Deniel C., Coton T., Brardjanian S., Guisset M., Nicand E., Simon F. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol: 2011; 51 3 202 204
77. Dumoulin F. L., Liese H. Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger? BMJ Case Rep: 2012;; pii: bcr1220115441
78. Fourquet E., Mansuy J. M., Bureau C., et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol: 2010; 48 1 73 74
79. Huang S., Zhang X., Jiang H., et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS ONE: 2010; 5 10 e13560
80. Bendall R., Ellis V., Ijaz S., Thurairajah P., Dalton H. R. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol: 2008; 80 1 95 101
81. Chauhan A., Jameel S., Dilawari J. B., Chawla Y. K., Kaur U., Ganguly N. K. Hepatitis E virus transmission to a volunteer. Lancet: 1993; 341 8838 149 150
82. Clayson E. T., Myint K. S., Snitbhan R., et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis: 1995; 172 4 927 933
83. Engle R. E., Yu C., Emerson S. U., Meng X. J., Purcell R. H. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol: 2002; 40 12 4576 4580
84. Emerson S. U., Clemente-Casares P., Moiduddin N., Arankalle V. A., Torian U., Purcell R. H. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol: 2006; 87 Pt 3 697 704
85. Legrand-Abravanel F., Mansuy J. M., Dubois M., et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis: 2009; 15 1 110 114
86. Drobeniuc J., Meng J., Reuter G., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis: 2010; 51 3 e24 e27
87. Herremans M., Bakker J., Duizer E., Vennema H., Koopmans M. P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol: 2007; 14 5 562 568
88. Mansuy J. M., Peron J. M., Bureau C., Alric L., Vinel J. P., Izopet J. Immunologically silent autochthonous acute hepatitis E virus infection in France. J Clin Microbiol: 2004; 42 2 912 913
89. Baylis S. A., Hanschmann K. M., Blümel J., Nübling C. M. HEV Collaborative Study Group Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol: 2011; 49 4 1234 1239
90. Dalton H. R., Bendall R. P., Keane F. E., Tedder R. S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med: 2009; 361 10 1025 1027
91. Kamar N., Rostaing L., Abravanel F., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology: 2010; 139 5 1612 1618
92. Tanaka T., Takahashi M., Kusano E., Okamoto H. Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J Gen Virol: 2007; 88 Pt 3 903 911
93. Shukla P., Nguyen H. T., Torian U., et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A: 2011; 108 6 2438 2443
94. Wu T., Zhang J., Su Z. J., et al. Specific cellular immune response in hepatitis E patients. Intervirology: 2008; 51 5 322 327
95. Husain M. M., Srivastava R., Akondy R., Aggarwal R., Jameel S., Naik S. Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology: 2011; 54 3 139 143
96. Colson P., Coze C., Gallian P., Henry M., De Micco P., Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis: 2007; 13 4 648 649
97. Matsubayashi K., Nagaoka Y., Sakata H., et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion: 2004; 44 6 934 940
98. Boxall E., Herborn A., Kochethu G., et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med: 2006; 16 2 79 83
99. Ijaz S., Szypulska R., Tettmar K. I., Kitchen A., Tedder R. S. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang: 2012; 102 3 272
100. Baylis S. A., Gärtner T., Nick S., Ovemyr J., Blümel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang: 2012; 103 1 89 90
101. Kamar N., Selves J., Mansuy J. M., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med: 2008; 358 8 811 817
102. Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., et al. Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis: 2011; 17 6 1074 1078
103. Renou C., Lafeuillade A., Cadranel J. F., et al. ANGH Hepatitis E virus in HIV-infected patients. AIDS: 2010; 24 10 1493 1499
104. Keane F., Gompels M., Bendall R., et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med: 2012; 13 1 83 88
105. Kaba M., Richet H., Ravaux I., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol: 2011; 83 10 1704 1716
106. Mateos-Lindemann M. L., Gonzalez-Galdámez A., Bordallo-Cardona M., Pérez-Gracia M. T. Are HIV-infected patients a high-risk population for hepatitis E virus infection in Spain? Enferm Infecc Microbiol Clin: 2012; 30 9 582 583
107. Jagjit Singh G. K., Ijaz S., Rockwood N., et al. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect Infect: 2013; 66 1 103 106
108. Crum-Cianflone N. F., Curry J., Drobeniuc J., et al. Infectious Disease Clinical Research Program HIV Working Group Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis: 2012; 18 3 502 506
109. Kaba M., Brouqui P., Richet H., et al. Hepatitis E virus infection in sheltered homeless persons, France. Emerg Infect Dis: 2010; 16 11 1761 1763
110. Larrat S., Gaillard S., Baccard M., et al. French National Agency for Research on AIDS and viral hepatitis HC02 Ribavic Study Team Hepatitis e virus infection in sheltered homeless persons, France. Emerg Infect Dis: 2012; 18 6 1031, author reply 1032
111. Goyal R., Kumar A., Panda S. K., Paul S. B., Acharya S. K. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther: 2012; 17 6 1091 1096
112. Péron J. M., Dalton H., Izopet J., Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol: 2011; 54 6 1323 1324, author reply 1324-1325
113. Zhu F. C., Zhang J., Zhang X. F., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet: 2010; 376 9744 895 902